AN2 THERAPEUTICS INC

Ticker: ANTX CUSIP: 037326105 Class: Common Stock

GEODE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001214717)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 251,875 Value ($000) $287 Avg Close $1.17 Range $1.01 - $1.37
Q3 2025
Shares 249,351 Value ($000) $317 Avg Close $1.14 Range $1.03 - $1.42
Q2 2025
Shares 249,351 Value ($000) $264 Avg Close $1.19 Range $1.01 - $1.42
Q1 2025
Shares 253,923 Value ($000) $345 Avg Close $1.26 Range $1.05 - $1.55
Q4 2024
Shares 227,796 Value ($000) $314 Avg Close $1.21 Range $0.97 - $1.68
Q3 2024
Shares 220,162 Value ($000) $236 Avg Close $1.74 Range $0.87 - $3.07
Q2 2024
Shares 180,923 Value ($000) $389 Avg Close $2.38 Range $1.91 - $3.88
Q1 2024
Shares 179,370 Value ($000) $583 Avg Close $10.88 Range $2.72 - $22.22
Q4 2023
Shares 178,623 Value ($000) $3,661 Avg Close $16.73 Range $13.51 - $21.70
Q3 2023
Shares 89,691 Value ($000) $1,443 Avg Close $11.32 Range $7.58 - $17.00
Q2 2023
Shares 52,962 Value ($000) $450 Avg Close $7.19 Range $4.87 - $10.85
Q1 2023
Shares 144,947 Value ($000) $1,431 Avg Close $11.12 Range $7.69 - $16.01
Q4 2022
Shares 123,085 Value ($000) $1 Avg Close $13.39 Range $8.30 - $21.04
Q3 2022
Shares 83,291 Value ($000) $1,447 Avg Close $11.66 Range $7.26 - $22.49
Q2 2022
Shares 76,467 Value ($000) $592 Avg Close $13.24 Range $6.88 - $23.58